Third quarter 2017 report and presentation

Posted on Nov 28, 2017

Oslo, 28 November 2017 – Please find enclosed the financial report and presentation for third quarter 2017. PCI Biotech Q3 2017 Report PCI Biotech Q3 2017 Presentation Granting of orphan status from the FDA was an important milestone for the fimaCHEM programme during Q3 2017, as was the inclusion of the first patient in the […]

Invitation to third quarter 2017 presentation

Posted on Nov 21, 2017

Oslo, 21 November 2017 – PCI Biotech invites to a presentation of the company’s third quarter 2017 report on Tuesday 28 November 2017 at Oslo Cancer Cluster Innovation Park. Time: Tuesday November 28, 08:30am – 09:30am CET (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo […]

Board of Directors update

Posted on Nov 9, 2017

Oslo, Norway, November 9, 2017 – Prof. Kjetil Taskén, MD, PhD has notified PCI Biotech Holding ASA’s Nomination Committee and Board of Directors that he is not able to be a candidate for re-election as Director of PCI Biotech Holding ASA’s Board of Directors at the next ordinary general meeting, in May 2018. Prof. Taskén […]